1.Influnce of MTHFR gene polymorphism on folicacid in lowering plasma homocyteine
The Journal of Practical Medicine 2014;(7):1091-1093
Objective To investigate the impact of methylene tetrahydrofolate reductase (MTHFR) gene polymorphism on folicacid for lowering plasma level of homocysteine in elderly patients with coronary heart disease (CHD). Methods In the first affiliated hospital of Zhengzhou university,a total of 180 elderly patients with CHD were randomized to two groups. The study group (91 ptients) received folicacid 5mg once daily and the control group (89 patients) received no folic acid. 8 weeks after treatment, the changes in plasma Hcy were observed and analyzed by MTHFR genotypes (TT vs. CC vs. CT). Results Plasma Hcy of the three genotypes had a statistical significance at the baseline (P<0.001), among which plasma Hcy level was the hightest in patients with genotype TT, while it had on difference in genotypes CC and CT (P = 0.057). 8 weeks after treatment, plasma Hcy level declined up to 24%in the patients with genotype TT in the study group, while it decreased about 6%and 15%in patients with genotype CC or CT, separately. Hcy level was slightly decreased in the patients with genotype CC, CT, or TT in the control group. Conclusions Plasma Hcy level differs statistically in three genotypes, and it is the highest in genotyp TT. Folicacid can effectively lower the level of plasma Hcy in elderly patients with CHD, especially those with genotype TT.
3.Impacts on chronic fatigue syndrome of qi deficiency syndrome and T cell subgroups in patients treated with acupuncture at selective time.
Jia-Yan LING ; Lin SHEN ; Qing LIU ; Ling-Yun WANG
Chinese Acupuncture & Moxibustion 2013;33(12):1061-1064
OBJECTIVETo verify the clinical efficacy on chronic fatigue syndrome of qi deficiency syndrome treated with acupuncture at selective time and explore the effect mechanism.
METHODSEighty patients were randomized into a selective-time-acupuncture group and an acupuncture group, 40 cases in each one. Qihai (CV 6), Guanyuan (CV 4), Hegu (LI 4), Taichong (LR 3), Sanyinjiao (SP 6) and Zusanli (ST 36) were selected in the two groups. In the selective-time-acupuncture group, acupuncture was used at 9:00am to 11:00am. In the acupuncture group, acupuncture was used at any time except in the range from 9:00am to 11:00am. No any manipulation was applied after the arrival of needling sensation. The treatment was given once every day, 10 day treatment made one session and two sessions of treatment were required. The fatigue scale was adopted to evaluate the efficacy before and after treatment in the patients of the two groups. The ratios among CD3+, CD4+ and CD8+ T cells in the peripheral blood were detected before ad b a after treatment.
RESULTSIn the acupuncture group, the total score of fatigue and the score of physical fatigue were reduced after treatment as compared with those before treatment (all P<0.05). In the selective-time -acupuncture group, the total score of fatigue, the s core of physical fatigue and the score of mental fatigue after treatment were reduced obviously as compared with those hefore treatment (all P<0. 01). The improvements in the scores of the selective-time-acupuncture group were superior to the acupuncture group (all P<0. 05). The ratio of CD3+ and CD8+ T cells was increased obviously after treatment in the two groups (all P<0. 05) and the ratio of CD4+ and CD8+ T cells was reduced obviously in the selective-time-acupuncture group (P<0. 05), which was better than that in the acupuncture group (all P<0.05). The total effective rate was 95.0% (38/40) in the selective-time-acupuncture group, which was better than 80.0% (32/40) in the acupuncture group (P<0.05).
CONCLUSIONThe acupuncture therapy at selective time is effective in the treatment of chronic fatigue syndrome of qi deficiency syndrome, which is especially better at relieving mental fatigue. The effect of this therapy is achieved probably by improving the immune function via the regulation of the ratios among CD3+, CD4+ and CD8+ T cells.
Acupuncture Points ; Acupuncture Therapy ; Adult ; Fatigue Syndrome, Chronic ; immunology ; therapy ; Female ; Humans ; Lymphocyte Count ; Male ; Middle Aged ; Qi ; T-Lymphocyte Subsets ; cytology ; immunology ; Treatment Outcome ; Young Adult
4.Effect of aspheric multifocal toric IOL implantation on visual acuity and contrast sensitivity in patients with cataract
Ling-Ling, ZHANG ; Yi-Jun, JIA ; Guang-Ying, ZHENG
International Eye Science 2016;16(7):1302-1305
AIM: To observe the effect of intraocular lens ( IOL) implantation on visual acuity and contrast sensitivity in patients with cataract.
METHODS: Fifty - eight cases ( 72 eyes ) cataract patients with regular cornel astigmatism, in our hospital from May 2014 to May 2015 were randomly divided into two groups to undergo phacoemulsification and IOL implantation: the observation group: 29 cases (36 eyes) received multifocal toric IOL implantation; the control group: 29 cases (36 eyes) received monofocal toric IOL implantation. Uncorrected distance visual acuity ( UCDVA), uncorrected near visual acuity ( UCNVA), best corrected distance visual acuity (BCDVA), the best corrected near visual acuity ( BCNVA ), total eye astigmatism, and the dark contrast sensitivity were observed for these patients at 1 and 6mo after cataract surgery.
RESULTS: There were no statistical significant difference between the two groups at postoperative 1, 6mo on UCDVA, BCNVA, BCDVA and total eye astigmatism(P>0. 05). UCNVA of observation group at 1 and 6mo were better than those of control group ( P <0. 05); there were statistically significant difference in high frequency comparison at the sixth postoperative months (P<0. 05).
CONCLUSION: Both monofocal toric IOL implantation, and aspheric multifocal toric IOL implantation for cataract with regular corneal astigmatism are effective to improve visual acuity. But the latter treatment would contribute to the improvement of uncorrected near visual acuity and the dark contrast sensitivity.
5.Origin and development of umbilical therapy in traditional Chinese medicine.
Chinese Acupuncture & Moxibustion 2014;34(6):607-610
The origin and development of umbilical therapy in traditional Chinese medicine is explored from related literature in the history. As a result, the Shang period is regarded as initial period of umbilical therapy, while periods from Han Dynasty, Jin Dynasty and Southern-Northern Dynasties to Sui Dynasty and Tang Dynasty could be taken as stage of primary development. Time from Song Dynasty, Jin Dynasty and Yuan Dynasty to Ming and Qing Dynasties is believed as mature stage. Also the manipulation, application principle, indications and contraindications of umbilical therapy are explained. A brief overview of modern development of umbilical therapy is also described.
China
;
History, 15th Century
;
History, 16th Century
;
History, 17th Century
;
History, 18th Century
;
History, 19th Century
;
History, 20th Century
;
History, Ancient
;
History, Medieval
;
Humans
;
Medicine in Literature
;
Medicine, Chinese Traditional
;
history
;
methods
;
Umbilicus
;
physiology
8.Study of the Relationship Among MVD,the Expression of Neu Gene and Estrogen Receptor and Prognosis in 94 Cases of Early Breast Cancer
Kunxian YANG ; Kunping CHI ; Ling JIA
Journal of Chinese Physician 2001;0(09):-
Objective To investigate the relationship among microvessel density (MVD),the expressions of Neu gene and estrogen receptor(ER) and prognosis in early breast cancer.Methods MVD,the expression of Neu gene and ER was examined in radical operation samples from 94 cases of breast cancer without lymphatic metastatis.Results The MVD, expression of Neu gene and ER in 94 cases of early breast cancer were 35 4?9 8,44 percent(41/94),61 percent (58/94)respectively;Three years after operation,16 cases had relapse in 94 cases of early breast cancer. The MVD of the relapse cases were 42 5?10 6, which was higher than that of non-relapse,whose MVD was 31 4?8 7,there was obvious difference(P0 05).Conclusions Whether there is a lymphoglandula metastasis is an important factor in evaluating prognosis of breast cancer.After radical operation there still are partly replase case in the breast cancer without lymphoglandula metastasis.MVD and Neu gene expression are important factors to estimate prognosis of the early breast cancer.Breast cancer which has higher MVD and Neu gene expression has worse prognosis than that of lower MVD and negative Neu gene expression. [
9.Detection and clinical studies of HER-2 in gastric cancer
Benli JIA ; Ling XIANGMENG ; Xin LIZHU
International Journal of Surgery 2011;38(7):487-491
Trastuzumab is a monoclonal antibody directed against the human epidermal growth factor receptor-2( HER-2). Recent studies found that Trastuzumab in combination with chemotherapy could improve the survival of patients with HER-2 positive advanced gastric. However, the use of techniques like immunohistochemistry, fluorescence in situ hybridization (FISH) in assessing HER-2 status of gastric cancer has many disadvantages, a new technique silver-enhanced in situ hybridization (SISH) is likely to be the reference standard for assessing HER-2 status of gastric cancer. This paper reviews the advance of the detection and clinical studies of HER-2 in gastric cancer.
10.Study on histone deacetylase inhibitor LBH589 reversal of multiple myeloma cells’ drug resistance mechanism in vitro
Ling ZHANG ; Yanping MA ; Gu JIA
Journal of Leukemia & Lymphoma 2013;22(1):50-52,56
Objective To study on a new generation of histone deacetylase inhibitor LBH589 on multiple myeloma (MM) resistant cells associated with changes in gene expression,and the mechanism of LBH589 reversal of MM cells' drug resistance.Methods By Western blot analysis,LBH589 (0,20,50 nmol/L) and 50 nmol/L LBH589 combined respectively with dexamethasone of 5 μmol/L at 24 h,expression of histone H4 acetylation and bcl-X gene on MMIR cells were detected.By real-time fluorescence quantitative PCR analysis,LBH589 (0,20,50 nmol/L) and 50 nmol/L LBH589 combined respectively with dexamethasone of 5 μmol/L at 24 h and 48 h,expression of TOSO on MM1R cells were detected.Results Western blot analysis showed that single LBH589 and combined with dexamethasone showed at 24 h the up-regulation on expression of the histone H4 acetylation[(0.205±0.008) %,(0.346±0.009) %,(0.580±0.053) %,(0.986±0.012) %,F =992.957,P =0.032],while down-regulation on expression of the bcl-X in MM1R cells in a dose-dependent manner[(1.210±0.160) %,(0.930±0.036) %,(0.730±0.017) %,(0.488±0.029) %,F =56.432,P =0.028].However,the group of single LBH589 was less effective than the combined group (all P < 0.05).Real-time fluorescence quantitative PCR analysis showed single LBH589 and that combined with dexamethasone showed at 24 h and 48 h,the down-regulation on expression of the TOSO in MM1R cells in a dose-dependent manner,24 h specific numerical were (1.00±0.00) %,(0.55±0.01) %,(0.47±0.01) %,(0.38±0.01) % (F =1006.344,P =0.041),48 h specific numerical were (1.00±0.00) %,(0.39±0.04) %,(0.05±0.01) %,(0.03±0.00) % (F =2383.977,P =0.045),however,the group of single LBH589 was less effective than the combined group (all P < 0.05).Conclusion Histone deacetylase inhibitor LBH589 can recover dexamethasone sensitivity of MM1R through effect the gene expression of bcl-X and TOSO,promot histone acetylation,and inducing cell apoptosis to treat tumor.